Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine.

ABSTRACT:

SUBMITTER: Tanaka F 

PROVIDER: S-EPMC8767873 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature